• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEPHA, INC. - 3005670760 GALAFLEX 3DR; ABSORBABLE MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEPHA, INC. - 3005670760 GALAFLEX 3DR; ABSORBABLE MESH Back to Search Results
Model Number 100043-02
Medical Device Problem Code Device Appears to Trigger Rejection (1524)
Health Effect - Clinical Codes Seroma (2069); Impaired Healing (2378)
Date of Event 10/03/2018
Type of Reportable Event Serious Injury
Event or Problem Description
Per clinical trial (b)(4): on (b)(6) 2018, patient underwent bilateral superior pedicle mastopexy using a vertical incision.2 pieces of galaform (galaflex 3dr) were used.Concomitant procedures included earlobe reduction, fat grafting to face, autoaugmentation liposuction to arms, thighs, back.On (b)(6) 2018, delayed wound healing of left breast was reported.There was a small open wound at the midpoint of the vertical incision of the left breast.On (b)(6) 2018 (same day), the area was debrided - there was exposed mesh at the base of the opening.No evidence of any wound infection.Patient probably had a seroma which drained simultaneously.Patient treated with polysporin and dressing changes.Resolution date and outcome unknown.Review by medical affairs identifies the delayed wound healing as likely related to the device and serious.
 
Additional Manufacturer Narrative
Based on the information available, no conclusions can be made.As reported the patient developed with delayed wound healing and seroma post implant of galaflex 3dr mesh and underwent subsequent surgical intervention.Medical affairs has assessed the ae as being likely related to the device and serious.Review of the device history records confirms the device was manufactured to specification.Seroma is a known inherent risk of surgery/use of the device and is included as a possible complication in the adverse reaction section of the instructions-for-use (ifu).Note: this mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr.All safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness.In an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GALAFLEX 3DR
Common Device Name
ABSORBABLE MESH
Manufacturer (Section D)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer (Section G)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key15711863
Report Number1213643-2022-00680
Device Sequence Number12419649
Product Code OOD
UDI-Device Identifier00855920006232
UDI-Public(01)00855920006232
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K162922
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/08/2019
Device Model Number100043-02
Device Catalogue NumberFR3D02
Device Lot Number180258
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/11/2022
Initial Report FDA Received Date11/01/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/22/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age55 YR
Patient SexFemale
Patient Weight86 KG
-
-